Most "recession-proof stocks" lists are written by sorting consumer-staples by yield and calling it a day. That's a different question from "which stocks actually survived 2008 and 2020 AND pass current value-investing screens AND are at acceptable prices today?"
The answer at the intersection is much narrower: 9 names. Each survived the last two major drawdowns with limited drawdown, maintained their dividends through both, and currently pass at least 5 of our 7 frameworks.
The criteria
We applied four filters in sequence:
- 2008 survival: maintained operations through 2008-2009, did not need a government bailout, did not cut its dividend by more than 20%.
- 2020 survival: maintained operations through COVID, did not need emergency capital raise, did not suspend its dividend.
- Current quality: passes at least 5 of the 7 value-investing frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith).
- Current price: not in extreme overvaluation (excludes anything with P/E > 50 unless growth justifies).
Only 9 stocks pass all four. Here they are.
The 9 recession-proof picks
Consumer staples (3)
-
Procter & Gamble (PG) - survived 2008 (revenue down only 3%, dividend raised), survived 2020 (revenue up actually, demand for hygiene + household goods spiked). Currently passes 5 of 7 frameworks. Yield 2.5%, A-grade dividend safety, 65+ consecutive years of dividend increases.
-
Johnson & Johnson (JNJ) - survived 2008 (revenue flat, raised dividend), survived 2020 (vaccine production gave it tailwind). Pharma + medical device + consumer staples diversification makes it the textbook defensive name. 60+ years of consecutive dividend raises.
-
Coca-Cola (KO) - survived 2008 (revenue down 3% in 2009 then recovered), survived 2020 (away-from-home revenue hit then bounced). Brand moat + global distribution = resilient.
Healthcare (2)
-
Pfizer-not-as-recession-proof - excluded. Different story (the recession was the COVID-cycle tailwind that's now reversing).
-
Becton Dickinson (BDX) - medical-device necessity. Recurring revenue from consumables (needles, blood-test kits, etc.) is one of the most recession-resilient income streams in the entire S&P 500. Survived 2008 and 2020 cleanly.
-
Stryker (SYK) - orthopedic devices + medical surgery equipment. Procedures get delayed in a downturn but not cancelled. Survived both 2008 and 2020 with limited drawdown.
Payment networks (2)
-
Visa (V) - counter-intuitive defensive name. Transaction volume held in 2008 and recovered fast in 2020. The toll-bridge model means recession reduces growth but never reverses revenue.
-
Mastercard (MA) - same thesis as Visa. Both passed 2008 with revenue flat, 2020 with revenue down ~10% then full recovery in 12 months.
Utilities and infrastructure (2)
-
Waste Management (WM) - garbage collection is the textbook recession-resilient business. Survived both periods with revenue down less than 5%. Increased dividends through both.
-
NextEra Energy (NEE) - regulated utility revenue. The bills get paid. Survived both with the regulatory rate-base shielding the business. Slow growth, reliable.
Why these 9 and not the usual suspects
Notable absences (and why they didn't make the strict filter):
- AT&T (T), Verizon (VZ) - high yield, but AT&T cut its dividend in 2022, removing it from the "consecutive raises" set. Fails dividend-safety threshold.
- Realty Income (O) - REIT, excluded from quality universe.
- 3M (MMM) - recent dividend cut + legal liabilities → D-grade safety.
- Berkshire Hathaway (BRK.B) - survived both periods cleanly but doesn't pass enough frameworks because Smith excludes banks (BRK owns GEICO, Burlington Northern, etc).
- Walmart (WMT) - survived 2008 (counter-cyclical actually), survived 2020. Currently passes only 4 frameworks (just under the 5-of-7 cutoff). Close to making the list.
- Costco (COST) - counter-cyclical in 2008. Currently passes 5 frameworks. Could be on the list; we excluded only because the dividend is small and the framework consensus is borderline.
The strict filter is recession resilience + current value-investing pass + current acceptable price. Most "defensive stocks" lists only check the first criterion. The intersection of all three is narrower.
What this list does NOT promise
Recession resilience is historical. A business that survived 2008 and 2020 might not survive the next recession - especially if the underlying business model has eroded since (KHC, AT&T are clean examples of names that would have made an earlier version of this list but no longer do).
The 9 names above are companies whose business model + balance sheet + management + framework consensus all align defensively today. They're not guarantees. The 2026 recession (if/when it happens) will have different shape than 2008 (financial crisis) or 2020 (pandemic).
How to verify
Every stock named has a live page on invest-like:
The 7-framework breakdown, dividend safety score, and 5-pillar verdict are all there with the underlying numbers.
How to use this in a defensive allocation
The honest workflow:
- Don't put your entire portfolio in these 9 names. Defensive ≠ no risk; concentration in 9 stocks is still concentrated.
- Pair these with index exposure. Even a 70% S&P 500 / 30% defensive single-stock allocation gives you most of the resilience with much less single-stock risk.
- Watch the framework consensus over time. Any of these dropping from 5-of-7 to 3-of-7 (the way KHC did) is the signal to reduce position.
- Don't chase yield. The high-yield names (T, VZ, O) all failed our strict filter. Yield without quality is a value trap.
Disclosure
Educational analysis. The 9 names are mechanical outputs of a 4-filter screen applied to current data + historical recession behaviour. They are not investment advice. Past recession-resilience does not guarantee future recession-resilience. The 2026 macro environment is different from 2008 and 2020, and the recession that ultimately tests these names will not look identical to either prior episode.
Author: Zaid Ghazal, founder of invest-like, indie SaaS, Kiel, Germany. Not a registered investment adviser.